KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Amortization - IntangiblesConsolidated Net IncomeCost of RevenueDepreciation & Amortization - TotalEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxRevenueSelling, General & AdministrativeShares OutstandingShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

Medpace Holdings (MEDP) Cost of Revenue (2016 - 2025)

Medpace Holdings (MEDP) has disclosed Cost of Revenue for 11 consecutive years, with $503.1 million as the latest value for Q4 2025.

  • For the quarter ending Q4 2025, Cost of Revenue rose 40.43% year-over-year to $503.1 million, compared with a TTM value of $1.8 billion through Dec 2025, up 21.81%, and an annual FY2025 reading of $1.8 billion, up 21.81% over the prior year.
  • Cost of Revenue was $503.1 million for Q4 2025 at Medpace Holdings, up from $463.0 million in the prior quarter.
  • Across five years, Cost of Revenue topped out at $503.1 million in Q4 2025 and bottomed at $181.5 million in Q1 2021.
  • Average Cost of Revenue over 5 years is $321.3 million, with a median of $346.2 million recorded in 2023.
  • The sharpest move saw Cost of Revenue fell 0.92% in 2024, then surged 40.43% in 2025.
  • Year by year, Cost of Revenue stood at $220.6 million in 2021, then increased by 26.2% to $278.4 million in 2022, then grew by 29.9% to $361.6 million in 2023, then fell by 0.92% to $358.3 million in 2024, then soared by 40.43% to $503.1 million in 2025.
  • Business Quant data shows Cost of Revenue for MEDP at $503.1 million in Q4 2025, $463.0 million in Q3 2025, and $423.3 million in Q2 2025.